Advances in Human Biology

EDITORIAL
Year
: 2023  |  Volume : 13  |  Issue : 1  |  Page : 1--3

Childhood tuberculosis - An emerging health challenge for Bangladesh


Kona Chowdhury1, Mainul Haque2,  
1 Department of Paediatrics, Gonoshasthaya Samaj Vittik Medical College and Hospital, Savar, Dhaka, Bangladesh
2 Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kuala Lumpur, Malaysia

Correspondence Address:
Prof. Mainul Haque
Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, 57000 Kuala Lumpur
Malaysia




How to cite this article:
Chowdhury K, Haque M. Childhood tuberculosis - An emerging health challenge for Bangladesh.Adv Hum Biol 2023;13:1-3


How to cite this URL:
Chowdhury K, Haque M. Childhood tuberculosis - An emerging health challenge for Bangladesh. Adv Hum Biol [serial online] 2023 [cited 2023 Feb 9 ];13:1-3
Available from: https://www.aihbonline.com/text.asp?2023/13/1/1/357311


Full Text

[INLINE:1]

Mycobacterium tuberculosis (TB) is the paramount basis of death from a single pathogenic microbe globally.[1],[2],[3] TB, one of humankind's oldest infectious diseases, still prevails as the significant cause of mortality. The anti-tubercular vaccine and drug therapies are available for over 90 and 60 years, respectively.[4],[5] While utmost TB diseases occur among the elderly community,[6],[7] children are a particular imminence category because of a higher possibility of quickly acquiring TB infection,[8],[9] with speedy advancement of the disease[10] and high death rate.[11] The World Health Organisation (WHO) reported that in 2020 that 10 million people were infected with TB; among them, 56%, 32% and 12% were men, women and children, respectively.[12] It has been appraised that around 3.5 million children will be infected with TB for a total of 40 million people around the globe in 2022.[13] Other research reported that something like 200,000 children passed away per year worldwide from 2016 to 2019.[14],[15],[16] Another study reported that 80% of these paediatric mortality were below 5 years, and 96% did not access medication.[17],[18] The WHO floated the 'End TB Strategy' in 2015 to minimise equally morbidity and mortality related to TB burden internationally by 2030.[19],[20] Bangladesh remains among the top eight nations, accounting for nearly 67% of the all-encompassing TB burden.[21] Multiple national reports from Bangladesh revealed that paediatric cases under 15 years of TB were below 5% of total cases between 2015 and 2019.[22],[23],[24],[25],[26],[27]

A child becomes infected with TB through respiratory droplets from other adolescent and adult pulmonary TB cases.[28] A significant portion of TB paediatric cases often develop such an infection as they live with adult family members who are sputum smear-positive TB cases.[29] Furthermore, children can acquire TB from their family members who have smear-negative TB disease.[30] The possibility of acquiring infection among children increases close contact, particularly when the mom or principal caregiver had pulmonary TB and it was confirmed radiographically.[31] Moreover, one meta-analysis revealed that children acquire TB infections besides household contacts.[32] Precise figures on children's TB infection are problematic to pick up because of manifold grounds that include underrated detection, difficulties in validating the diagnosis and under-reporting to the accountable public healthcare system.[2],[33] The symptoms, signs and roentgenogram features are less precise among children than adults[34] and are frequently chaotic with other acute respiratory microbial infections.[35] Microbiologic endorsement of the disease is often inadequate because of the paucibacillary nature of childhood TB.[34],[36] Furthermore, microbiological proof is regularly challenging to attain as childhood pulmonary TB cases are hardly ever able to expectorated sputum, and sputum initiation procedures or other sampling methods are expensive and not accessible in real-life in low-income and high-burden countries.[37] In addition, smear microscopy's sensitivity for childhood TB diagnosis remains <15% under the optimal conditions.[38],[39]

Bangladesh is well recognised worldwide for effectively executing the TB control programme.[40],[41],[42] Bangladesh's childhood TB detection rate is persisting at <5% for the past few years.[16] Bangladesh government has formulated and implemented childhood TB management guidelines, and notification of TB cases has been mandatory within the National Tuberculosis Programme.[16] Despite those steps, several obstacles persist, preventing our goal of end TB strategy. Insufficiency of the diagnostic facility, lack of interest in the notification of cases by private practitioners and social disgrace is slowing our progress.[16] Nevertheless, the country has achieved a lot regarding paediatric TB control but still has a long way to go to reach the WHO goal.[43]

TB in children indicates ongoing infection in the community,[44] and they are at the highest risk of progressing, disease-causing significant morbidity and mortality.[45] Despite Bangladesh and other low- and middle-income-countries having limited diagnostic faculties and minimum access to the long-term therapeutic management of TB, it is believed that initiating appropriate strategies at the right time has a favourable outcome.[46],[47] Public healthcare authorities should undertake more initiatives to raise community awareness, involvement of private practitioners and increase service providers' capacity.

References

1Rens C, Chao JD, Sexton DL, Tocheva EI, Av-Gay Y. Roles for phthiocerol dimycocerosate lipids in Mycobacterium tuberculosis pathogenesis. Microbiology (Reading) 2021;167:001042.
2Thomas TA. Tuberculosis in children. Pediatr Clin North Am 2017;64:893-909.
3MacNeil A, Glaziou P, Sismanidis C, Maloney S, Floyd K. Global epidemiology of tuberculosis and progress toward achieving global targets – 2017. MMWR Morb Mortal Wkly Rep 2019;68:263-6.
4Bloom BR, Atun R, Cohen T, Dye C, Fraser H, Gomez GB, et al. Tuberculosis. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Major Infectious Diseases. 3rd ed. Ch. 11. Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2017. Available from: https://www.ncbi.nlm.nih.gov/books/NBK525174/doi: 10.1596/978-1-4648-0524-0_ch11. [Last accessed on 2022 Aug 31].
5Barberis I, Bragazzi NL, Galluzzo L, Martini M. The history of tuberculosis: From the first historical records to the isolation of Koch's bacillus. J Prev Med Hyg 2017;58:E9-12.
6Caraux-Paz P, Diamantis S, de Wazières B, Gallien S. Tuberculosis in the elderly. J Clin Med 2021;10:5888.
7Hase I, Toren KG, Hirano H, Sakurai K, Horne DJ, Saito T, et al. Pulmonary tuberculosis in older adults: Increased mortality related to tuberculosis within two months of treatment initiation. Drugs Aging 2021;38:807-15.
8Narasimhan P, Wood J, Macintyre CR, Mathai D. Risk factors for tuberculosis. Pulm Med 2013;2013:828939.
9Martinez L, Cords O, Horsburgh CR, Andrews JR, Pediatric TB Contact Studies Consortium. The risk of tuberculosis in children after close exposure: A systematic review and individual-participant meta-analysis. Lancet 2020;395:973-84.
10Roya-Pabon CL, Perez-Velez CM. Tuberculosis exposure, infection and disease in children: A systematic diagnostic approach. Pneumonia (Nathan) 2016;8:23.
11Jenkins HE, Yuen CM, Rodriguez CA, Nathavitharana RR, McLaughlin MM, Donald P, et al. Mortality in children diagnosed with tuberculosis: A systematic review and meta-analysis. Lancet Infect Dis 2017;17:285-95.
12Global Tuberculosis Report 2020: Executive Summary. Geneva: World Health Organization; 2020. Available from: https://apps.who.int/iris/bitstream/handle/10665/337538/9789240016095-eng.pdf. [Last accessed on 2022 Aug 31].
13Petersen E, Al-Abri S, Chakaya J, Goletti D, Parolina L, Wejse C, et al. World TB day 2022: Revamping and reshaping global TB control programs by advancing lessons learnt from the COVID-19 pandemic. Int J Infect Dis 2022;S1201-9712(22): 00138-2.
14GBD Tuberculosis Collaborators. Global, regional, and national burden of tuberculosis, 1990-2016: Results from the global burden of diseases, injuries, and risk factors 2016 study. Lancet Infect Dis 2018;18:1329-49.
15Nkereuwem E, Kampmann B, Togun T. The need to prioritise childhood tuberculosis case detection. Lancet 2021;397:1248-9.
16Pantha S, Aguinaldo MJ, Hasan-Ul-Bari SM, Chowdhury S, Dendup U, Gupta RD, et al. Facilitators and barriers to implementation of a childhood tuberculosis control program in Bangladesh: A mixed-methods study from BRAC Urban DOTS centres in Dhaka. Nurs Rep 2022;12:371-86.
17Dodd PJ, Yuen CM, Sismanidis C, Seddon JA, Jenkins HE. The global burden of tuberculosis mortality in children: A mathematical modelling study. Lancet Glob Health 2017;5:e898-906.
18Awaluddin SM, Ismail N, Zakaria Y, Yasin SM, Razali A, Mutalip MH, et al. Characteristics of paediatric patients with tuberculosis and associated determinants of treatment success in Malaysia using the MyTB version 2.1 database over five years. BMC Public Health 2020;20:1903.
19Raviglione M, Sulis G. Tuberculosis 2015: Burden, challenges and strategy for control and elimination. Infect Dis Rep 2016;8:6570.
20Avoi R, Liaw YC. Tuberculosis death epidemiology and its associated risk factors in Sabah, Malaysia. Int J Environ Res Public Health 2021;18:9740.
21Chakaya J, Khan M, Ntoumi F, Aklillu E, Fatima R, Mwaba P, et al. Global tuberculosis report 2020 – Reflections on the global TB burden, treatment and prevention efforts. Int J Infect Dis 2021;113 Suppl 1:S7-12.
22National Tuberculosis Program. Tuberculosis Control in Bangladesh Annual Report 2015; National Tuberculosis Control Program, Directorate General of Health Services: Dhaka, Bangladesh, 2015. Available ftom: https://www.ntp.gov.bd/wp-content/uploads/2021/07/NTP-Annual-Report-2015.pdf. [Last accessed on 2022 Aug 31].
23National Tuberculosis Program. Tuberculosis Control in Bangladesh Annual Report 2016; National Tuberculosis Control Program, Directorate General of Health Services: Dhaka, Bangladesh, 2016. Available from: https://www.ntp.gov.bd/wp-content/uploads/2021/07/1487245939.pdf. [Last accessed on 2022 Aug 31].
24National Tuberculosis Program. Tuberculosis Control in Bangladesh Annual Report 2016; National Tuberculosis Control Program, Directorate General of Health Services: Dhaka, Bangladesh, 2017. Available from: https://www.ntp.gov.bd/wp-content/uploads/2021/07/NTP-Annual-Report-2017.pdf. [Last accessed on 2022 Aug 31].
25National Tuberculosis Program. Tuberculosis Control in Bangladesh Annual Report 2016; National Tuberculosis Control Program, Directorate General of Health Services: Dhaka, Bangladesh, 2018. Available from: https://www.ntp.gov.bd/wp-content/uploads/2021/07/Annual-Report-2018.pdf. [Last accessed on 2022 Aug 31].
26National Tuberculosis Program. Tuberculosis Control in Bangladesh Annual Report 2016; National Tuberculosis Control Program, Directorate General of Health Services: Dhaka, Bangladesh, 2019. Available from: https://www.ntp.gov.bd/wp-content/uploads/2021/07/Annual-Report-2019.pdf. [Last accessed on 2022 Aug 31].
27National Tuberculosis Control Program. Tuberculosis Control in Bangladesh Annual Report 2020; National Tuberculosis Control Program, Directorate General of Health Services: Dhaka, Bangladesh, 2020. Available from: https://www.ntp.gov.bd/wp-content/uploads/2021/09/Annual-Report-2020.pdf. [Last accessed on 2022 Aug 31].
28Matlow A, Robb M, Goldman C. Infection control and paediatric tuberculosis: A practical guide for the practicing paediatrician. Paediatr Child Health 2003;8:624-6.
29Srivastava G, Faridi MM, Gupta SS. Tubercular infection in children living with adults receiving Directly Observed Treatment Short course (DOTS): A follow up study. BMC Infect Dis 2020;20:720.
30Carvalho I, Goletti D, Manga S, Silva DR, Manissero D, Migliori G. Managing latent tuberculosis infection and tuberculosis in children. Pulmonology 2018;24:106-14.
31Laghari M, Sulaiman SA, Khan AH, Talpur BA, Bhatti Z, Memon N. Contact screening and risk factors for TB among the household contact of children with active TB: A way to find source case and new TB cases. BMC Public Health 2019;19:1274.
32Martinez L, Shen Y, Mupere E, Kizza A, Hill PC, Whalen CC. Transmission of mycobacterium tuberculosis in households and the community: A systematic review and meta-analysis. Am J Epidemiol 2017;185:1327-39.
33Reuter A, Hughes J, Furin J. Challenges and controversies in childhood tuberculosis. Lancet 2019;394:967-78.
34Nicol MP, Zar HJ. Advances in the diagnosis of pulmonary tuberculosis in children. Paediatr Respir Rev 2020;36:52-6.
35Wei M, Zhao Y, Qian Z, Yang B, Xi J, Wei J, et al. Pneumonia caused by Mycobacterium tuberculosis. Microbes Infect 2020;22:278-84.
36García-Basteiro AL, López-Varela E, Augusto OJ, Gondo K, Muñoz J, Sacarlal J, et al. Radiological findings in young children investigated for tuberculosis in Mozambique. PLoS One 2015;10:e0127323.
37DiNardo AR, Detjen A, Ustero P, Ngo K, Bacha J, Mandalakas AM. Culture is an imperfect and heterogeneous reference standard in pediatric tuberculosis. Tuberculosis (Edinb) 2016;101S: S105-8.
38Sudbury EL, Otero L, Tebruegge M, Messina NL, Seas C, Montes M, et al. Mycobacterium tuberculosis-specific cytokine biomarkers for the diagnosis of childhood TB in a TB-endemic setting. J Clin Tuberc Other Mycobact Dis 2019;16:100102.
39Sorsa A, Jerene D, Negash S, Habtamu A. Use of Xpert contributes to accurate diagnosis, timely initiation, and rational use of anti-TB treatment among childhood tuberculosis cases in South Central Ethiopia. Pediatric Health Med Ther 2020;11:153-60.
40Aung KJ, Van Deun A, Declercq E, Sarker MR, Das PK, Hossain MA, et al. Successful '9-month Bangladesh regimen' for multidrug-resistant tuberculosis among over 500 consecutive patients. Int J Tuberc Lung Dis 2014;18:1180-7.
41Lalloo UG. Short-course Bangladesh regimen for multidrug-resistant tuberculosis: A step in the right direction? Int J Tuberc Lung Dis 2014;18:1137-8.
42Kak N, Chakraborty K, Sadaphal S, AlMossawi HJ, Calnan M, Vikarunnessa B. Strategic priorities for TB control in Bangladesh, Indonesia, and the Philippines – Comparative analysis of national TB prevalence surveys. BMC Public Health 2020;20:560.
43Islam Z, Sanin KI, Ahmed T. Improving case detection of tuberculosis among children in Bangladesh: Lessons learned through an implementation research. BMC Public Health 2017;17:131.
44Singh AR, Kumar A, Shewade HD, Dhingra B. Poor adherence to TB diagnosis guidelines among under-five children with severe acute malnutrition in central India: A missed window of opportunity? PLoS One 2021;16:e0248192.
45Basu Roy R, Whittaker E, Seddon JA, Kampmann B. Tuberculosis susceptibility and protection in children. Lancet Infect Dis 2019;19:e96-108.
46Getnet F, Demissie M, Assefa N, Mengistie B, Worku A. Delay in diagnosis of pulmonary tuberculosis in low-and middle-income settings: Systematic review and meta-analysis. BMC Pulm Med 2017;17:202.
47Laurence YV, Griffiths UK, Vassall A. Costs to health services and the patient of treating tuberculosis: A systematic literature review. Pharmacoeconomics 2015;33:939-55.